Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)

Cooper Companies (COO) recorded quarterly Non-Current Deffered Revenue of $208.8 million in Q2 2026, up 1.16% quarter-over-quarter from $206.4 million in Q1 2026, and up 6.31% year-on-year from $196.4 million in Q2 2025.

Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

Cooper Companies has disclosed Non-Current Deffered Revenue across 6 years of filings, most recently posting $208.8 million for Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million; the trailing twelve-month figure through Apr 2026 stood at $208.8 million (up 6.31% YoY), and the FY2025 full-year result was $201.8 million, up 4.4% from the prior year.
  • Non-Current Deffered Revenue was $208.8 million for Q2 2026 at Cooper Companies, up from $206.4 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $208.8 million in Q2 2026 and troughed at $182.6 million in Q2 2023.
  • The 5-year median for Non-Current Deffered Revenue is $193.4 million (2025), against an average of $194.1 million.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue surged 198200.0% in 2022, then declined 7.11% in 2023.
  • Year by year, Non-Current Deffered Revenue stood at $198.3 million in 2022, then declined by 7.11% to $184.2 million in 2023, then advanced by 4.94% to $193.3 million in 2024, then rose by 4.4% to $201.8 million in 2025, then gained by 3.47% to $208.8 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $208.8 million in Q2 2026, $206.4 million in Q1 2026, and $201.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 163.15 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 11.80 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 208.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2026 208.80 Mn
Jan 31, 2026 206.40 Mn
Oct 31, 2025 201.80 Mn
Jul 31, 2025 199.40 Mn
Apr 30, 2025 196.40 Mn
Jan 31, 2025 193.40 Mn
Oct 31, 2024 193.30 Mn
Jul 31, 2024 190.80 Mn
Apr 30, 2024 188.60 Mn
Jan 31, 2024 186.30 Mn
Oct 31, 2023 184.20 Mn
Jul 31, 2023 185.50 Mn
Apr 30, 2023 182.60 Mn
Jan 31, 2023 195.10 Mn
Oct 31, 2022 198.30 Mn
Oct 31, 2021 100,000.00